In neuroblastoma cell lines expressing high ALDH1A3 levels, ALDH1A3 knockout via CRISPR/Cas9 gene editing reduced clonogenicity and mediated cell type-dependent inhibition of self-renewal properties of tumor inducing cells (50). The gene discussed is ALDH1A3; the disease is neoplasm.